Dexamethasone ophthalmic Alternatives Compared
Dexamethasone ophthalmic Remove Dexamethasone ophthalmic from your drug comparison | Lotemax Remove Lotemax from your drug comparison | Sulfacetamide sodium ophthalmic Remove Sulfacetamide sodium ophthalmic from your drug comparison |
---|
Dexamethasone ophthalmic Remove Dexamethasone ophthalmic from your drug comparison | Lotemax loteprednol Remove Lotemax from your drug comparison | Sulfacetamide sodium ophthalmic Remove Sulfacetamide sodium ophthalmic from your drug comparison | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescribed for Macular Edema, Uveitis, Conjunctivitis, Iritis, Uveitis - Posterior, Keratitis, Cyclitis, Diabetic Macular Edema, Postoperative Ocular Inflammation. dexamethasone ophthalmic may also... View more |
Prescribed for Conjunctivitis, Keratitis, Cyclitis, Iritis, Postoperative Ocular Inflammation, Rosacea, Seasonal Allergic Conjunctivitis. Lotemax may also be used for purposes not listed in this... View more |
Prescribed for Conjunctivitis, Eye Conditions, Trachoma. sulfacetamide sodium ophthalmic may also be used for purposes not listed in this medication guide. |
||||||||||||||||||||||||
Prescription only |
Prescription only |
Prescription only |
||||||||||||||||||||||||
Ratings & Reviews |
||||||||||||||||||||||||||
Drug Class |
||||||||||||||||||||||||||
Side Effects |
||||||||||||||||||||||||||
See the full dexamethasone ophthalmic side effects document. |
See the full Lotemax side effects document. |
See the full sulfacetamide sodium ophthalmic side effects document. |
||||||||||||||||||||||||
Pricing and Coupons* Prices are without insurance |
||||||||||||||||||||||||||
View all dexamethasone ophthalmic prices |
View all Lotemax prices and generic prices |
|
||||||||||||||||||||||||
Generic Availability |
||||||||||||||||||||||||||
Yes (this medicine) |
Yes (this medicine) |
|||||||||||||||||||||||||
Dosage Form(s) Available |
||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names |
||||||||||||||||||||||||||
AK-Dex, Decadron Ocumeter, Decadron Phosphate, Ophthalmic, Dexasol, Dextenza, Dexycu, Maxidex, Ozurdex | Other loteprednol brands include: Alrex, Eysuvis, Inveltys, Lotemax SM | AK-Sulf, Bleph-10, Cetamide | ||||||||||||||||||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
CSA Schedule**View glossary of terms. |
||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category |
||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
||||||||||||||||||||||||
FDA Alerts |
||||||||||||||||||||||||||
N/A |
N/A |
|||||||||||||||||||||||||
Drug Interactions |
||||||||||||||||||||||||||
A total of 80 drugs are known to interact with dexamethasone ophthalmic:
|
A total of 36 drugs are known to interact with Lotemax:
|
A total of 1 drugs are known to interact with sulfacetamide sodium ophthalmic:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions |
||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions |
||||||||||||||||||||||||||
First Approval Date |
||||||||||||||||||||||||||
June 17, 2009 |
April 15, 2011 |
July 21, 1946 |
||||||||||||||||||||||||
WADA ClassView World Anti-Doping Agency classifications. |
||||||||||||||||||||||||||
N/A |
N/A |
|||||||||||||||||||||||||
More Information |
||||||||||||||||||||||||||
Consumer Resources |
||||||||||||||||||||||||||
N/A |
||||||||||||||||||||||||||
Professional Resources |
||||||||||||||||||||||||||
Related Treatment Guide |
||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.